5 Best Genomics Stocks To Buy Now

2. Illumina, Inc. (NASDAQ:ILMN)

Number of Hedge Fund Investors In Q3 2023: 40

Illumina, Inc. (NASDAQ:ILMN) is another scientific products company that caters to the needs of the genomics industry. The firm has beaten analyst EPS estimates in all four of its latest quarters and the shares are rated Buy on average.

By the end of this year’s third quarter, 40 out of the 910 hedge funds covered by Insider Monkey’s research had invested in the company. Illumina, Inc. (NASDAQ:ILMN)’s biggest investor among these is Guardian Capital’s GuardCap Asset Management as it owns 2 million shares that are worth $286 million.

Follow Illumina Inc. (NASDAQ:ILMN)